Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 53 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Dr. Evy Vandemeulebroucke, Endocrinologie from Boortmeerbeek, company number BE0552741434, closed financial year 2025 with a result of € 235,575 after tax. For that financial year Dr. Evy Vandemeulebroucke, Endocrinologie recorded a gross margin of € 334,078 and equity of € 20,460. Compared with financial year 2024, the result moved from € 255,198 to € 235,575. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2026.
€ 20,460
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 235,575
▼ 8% vs 2024
Profit after tax over the fiscal year.
€ 330,082
▼ 16% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 235,575 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 60,206
▼ 25% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3,435
▲ 8% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 360
▼ 99% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 314,241 | € 366,913 | € 360,081 | € 334,078 | ▼ 7% |
| Profit after taxes | € 230,046 | € 275,886 | € 255,198 | € 235,575 | ▼ 8% |
| Equity | € 20,460 | € 20,460 | € 20,460 | € 20,460 | |
| Total debts | € 296,007 | € 532,572 | € 695,093 | € 641,728 | ▼ 8% |
| Cash | € 166,348 | € 361,559 | € 391,459 | € 330,082 | ▼ 16% |
| Land & buildings | € 7,224 | € 5,418 | € 3,612 | € 1,806 | ▼ 50% |
| Retained profit | € 1,860 | € 1,860 | € 1,860 | € 1,860 | |
| Dividend | € 230,046 | € 275,886 | € 255,198 | € 235,575 | ▼ 8% |
| Balance sheet total | € 316,467 | € 553,032 | € 715,553 | € 662,188 | ▼ 7% |
Key figures of Dr. Evy Vandemeulebroucke, Endocrinologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Dr. Evy Vandemeulebroucke, Endocrinologie the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Dr. Evy Vandemeulebroucke, Endocrinologie?
What happened at Dr. Evy Vandemeulebroucke, Endocrinologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 235,575 (▼ 8% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Boortmeerbeek. KBO
In short
From € 230,046 profit in 2022 to € 235,575 profit in 2025.
Paid € 333,115 in corporate taxes since 2022.
Best year ever: 2023, with € 275,886 profit.
Paid out € 996,704 in dividends to the owners in total.
Management
Behind Dr. Evy Vandemeulebroucke, Endocrinologie is Evy Vandemeulebroucke.
Directors
According to the 2025 annual accounts
Evy Vandemeulebroucke
Director
Establishments
Establishment units
Physical locations of this company
Consciencelaan 4
3191 Boortmeerbeek
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- VANDEMEULEBROUCKE Evy(oprichter) 100%
Incorporation
Source: Deed ↗- VANDEMEULEBROUCKE Evy(oprichter) 100%
Details
- Company number
- 0552.741.434
- VAT number
- BE 0552.741.434
- Registered office
- Consciencelaan 4, 3191 Boortmeerbeek
- Names & denominations
- Dr. Evy Vandemeulebroucke, Endocrinologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 May 2014
- Peppol
- Active · Active since 9 Jul 2025
- Activities · NACE
Activiteiten op het gebied van voeding
Overige menselijke gezondheidszorg, n.e.g.
Activiteiten van huisartspraktijken